Cannabinoid CB2 ligands (Roche)

N/A

Report date: 2025/06/11 11:23:03

Base Information

Drug NameCannabinoid CB2 ligands (Roche)

Drug Alias Name11C-RETH-211C-RETH-1

ClassificationRadiation-emitting productsDiagnostic agent (In vivo)

Mechanisms of ActionPositron-emission tomography enhancersCannabinoid CB2 receptor agonists

TargetsCannabinoid CB2 receptor

Therapy Area/IndicationsCentral Nervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRoche Holding Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCentral Nervous System Diseases

Inactive IndicationsN/A

ATC CodeN/A